13 Best Growth Stocks Under $50 to Buy Now

Page 10 of 12

3. Bristol-Myers Squibb Company (NYSE:BMY)

Stock Price: $47.14

Number of Hedge Fund Holders: 67

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best growth stocks under $50 to buy now. On September 8, BMO Capital analyst Evan Seigerman maintained a Hold rating on Bristol-Myers Squibb Company (NYSE:BMY), retaining the price target of $47.00.

The analyst attributed the rating to the performance of Cobenfy, the company’s new product, in the market, stating that its growth has been stable with a modest percentage increase in the weekly prescription rates.

However, he added that the growth failed to meet the levels expected by some investors for H2 2025. The revenue estimates for the product in Q3 fall slightly below consensus estimates, supporting the Hold rating.

Bristol-Myers Squibb Company (NYSE:BMY) is a biopharmaceutical company that discovers, develops, and delivers advanced medicines for serious diseases. Its medicines fall into various therapeutic classes, including hematology, oncology, cardiovascular, immunology, and neuroscience.

Page 10 of 12